Answers are grounded in this paper and cite their sources.
Multicomponent reactions (MCRs) are not only a powerful tool for drug discovery, they also represent an excellent methodology for synthesis rationalization. Here we wish to illustrate the potential of MCRs in the production of generic drugs by synthesizing, in racemic form, the antiplatelet agent clopidogrel and the non-steroidal antiandrogen bicalutamide, using Ugi, Petasis and Passerini reactions.
No takes yet. Share an insight, caveat, or question.
Kalinski et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: